Clinical Trial Update: To Evaluate the Characteristics of a Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update notes that the EARLY Phase 1 study evaluating the characteristics of breast cancer (NCT01055678) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mark Dewhirst | Conditions: Breast Cancer | EARLY_Phase 1 | Status: WITHDRAWN